| Model 1 | Model 2 | Model 3 |
---|
HR | 95% CI | P-value | HR | 95%CI | P-value | HR | 95% CI | P-value |
---|
TyG index | 1.274 | 1.114–1.456 | < 0.001 | 1.201 | 1.047–1.377 | 0.009 | 1.191 | 1.038–1.367 | 0.013 |
TyG tertiles |
 T1 | Reference |  |  | Reference |  |  | Reference |  |  |
 T2 | 1.301 | 1.050–1.612 | 0.016 | 1.212 | 0.974–1.509 | 0.085 | 1.194 | 0.959–1.487 | 0.112 |
 T3 | 1.432 | 1.162–1.765 | < 0.001 | 1.338 | 1.078–1.659 | 0.008 | 1.319 | 1.063–1.637 | 0.012 |
P for trend |  |  | < 0.001 |  |  | 0.009 |  |  | 0.013 |
- Model 1: unadjusted
- Model 2: adjusted for age, sex, BMI, previous PCI, presence of PAD, presence of multivessel CAD, high-sensitivity CRP, eGFR, presence of lesion’s length ≥ 20 mm
- Model 3: adjusted for age, sex, BMI, previous PCI, presence of PAD, presence of multivessel CAD, high-sensitivity CRP, eGFR, presence of lesion’s length ≥ 20 mm, stent length
- BMI body mass index, CI confidence interval, CAD coronary artery disease, CRP C-reactive protein, eGFR estimated glomerular filtration rate, HR hazard ratio, PCI percutaneous coronary intervention, PAD peripheral artery disease, TyG triglyceride-glucose